This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
AWMF. AWMF-Leitlinie 025/016: Sichelzellkrankheit. In: AWMF: Cario, Holger; Grosse, Regine; Jarisch, Andrea; Lobitz, Stephan; Kulozik, Andreas; Kunz, Joachim, 2014.
Foell J, Pfirstinger B, Rehe K, Wolff D, Holler E, Corbacioglu S. Haploidentical stem cell transplantation with CD3(+)-/CD19(+)- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study. Bone Marrow Transpl. 2017;52:938–40. https://doi.org/10.1038/bmt.2017.49
Bolanos-Meade J, Fuchs EJ, Luznik L, Lanzkron SM, Gamper CJ, Jones RJ, et al. HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood. 2012;120:4285–91. https://doi.org/10.1182/blood-2012-07-438408
Zerr DM. Human herpesvirus 6B in the transplant recipient: when to worry, when to act. J Pediatr Infect Dis Soc. 2018;7:S75–S78. https://doi.org/10.1093/jpids/piy111. Review
Greco R, Crucitti L, Noviello M, Racca S, Mannina D, Forcina A, et al. Human herpesvirus 6 infection following haploidentical transplantation: immune recovery and outcome. Biol Blood Marrow Transpl. 2016;22:2250–5. https://doi.org/10.1016/j.bbmt.2016.09.018
Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, et al. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol. 2014;159:863–70. https://doi.org/10.1007/s00705-013-1902-5
Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol. 1999;73:8040–52.
Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994;331:432–8. https://doi.org/10.1056/NEJM199408183310703
Osterrieder N, Wallaschek N, Kaufer BB. Herpesvirus genome integration into telomeric repeats of host cell chromosomes. Annu Rev Virol. 2014;1:215–35. https://doi.org/10.1146/annurev-virology-031413-085422
Endo A, Watanabe K, Ohye T, Suzuki K, Matsubara T, Shimizu N, et al. Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency. Clin Infect Dis. 2014;59:545–8. https://doi.org/10.1093/cid/ciu323
Winestone LE, Punn R, Tamaresis JS, Buckingham J, Pinsky BA, Waggoner JJ, et al. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality. Pediatr Transplant. 2018;22. https://doi.org/10.1111/petr.13084.
Phan TL, Carlin K, Ljungman P, Politikos I, Boussiotis V, Boeckh M, et al. Human herpesvirus-6B reactivation is a risk factor for grades II to IV acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis. Biol Blood Marrow Transpl. 2018;24:2324–36. https://doi.org/10.1016/j.bbmt.2018.04.021
Ogata M, Fukada T, Teshima T. Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transpl. 2015;50:1030–6. https://doi.org/10.1038/bmt.2015.76.
Bonnafous P, Marlet J, Bouvet D, Salame E, Tellier AC, Guyetant S, et al. Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation. Am J Transpl. 2018;18:1548–51. https://doi.org/10.1111/ajt.14657
Prichard MN, Whitley RJ. The development of new therapies for human herpesvirus 6. Curr Opin Virol. 2014;9:148–53. https://doi.org/10.1016/j.coviro.2014.09.019
Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35:3547–57. https://doi.org/10.1200/JCO.2017.73.0655
Acknowledgements
L.O. and A.K. are participants in the BIH‐Charité Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berliner Institut für Gesundheitsforschung (BIH). This work was supported by a grant to L.O. from Bild Hilft e.V. – Ein Herz für Kinder and by the HHV-6 Foundation, who provided the anti-gp82/105 antibody. The anti-IE-1 antibody was kindly provided by L. Flamand and colleagues from the Laval University (Sainte-Foy, Quebec, Canada). We thank Kathy Astrahantseff for proofreading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Oevermann, L., Zimmermann, C., Voigt, S. et al. Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications. Bone Marrow Transplant 55, 260–264 (2020). https://doi.org/10.1038/s41409-019-0530-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-019-0530-4